Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a gout drug help heal brain bleeds?

NCT ID NCT07701512

Recruiting now Disease control Sponsor: Tanta University Source: ClinicalTrials.gov ↗

First seen Jul 14, 2026 · Last updated Jul 16, 2026 · Updated 2 times

Summary

This trial tests whether febuxostat, a drug typically used for gout, can improve recovery in people with a brain bleed (intracranial hemorrhage) who are treated without surgery. Participants take febuxostat or standard care for three months. The study measures consciousness levels and blood markers of inflammation to see if the drug helps reduce brain injury.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
febuxostat, a drug that lowers uric acid and may reduce inflammation
What this could lead to
If it works, this could point toward a simple, low-cost drug to help people recover from a brain bleed without needing surgery.
What could go wrong
This is a small, early-phase trial with only 46 participants, so results may not apply broadly. Febuxostat is not proven for this use and could have side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACRANIAL HEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intracerebral hemorrhage Intracranial Hemorrhages

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTRACRANIAL HEMORRHAGE

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Neurosurgery department Mansoura university hospitals

    RECRUITING

    Al Mansurah, Dakahlia Governorate, 35511, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.